Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 109

Results For "X"

9450 News Found

Venus Remedies recognized for R&D excellence by DSIR
News | May 19, 2023

Venus Remedies recognized for R&D excellence by DSIR

Leading Research-driven Pharma Company Combats Antibiotic Resistance and Demonstrates Innovation in Medical Solutions


Thermo Fisher Scientific expands ImmunoCAP test availability across U.S.
News | May 19, 2023

Thermo Fisher Scientific expands ImmunoCAP test availability across U.S.

Testing supporting allergy diagnosis now accessible to more people in more communities


Emcure Pharmaceuticals to launch the750 mg injectable variant of ferric carboxymaltose
News | May 17, 2023

Emcure Pharmaceuticals to launch the750 mg injectable variant of ferric carboxymaltose

Single dose of Ferric Carboxymaltose (FCM) up to 750 mg of iron can be infused in 15 minutes


Farxiga’s expanded approval highlights potential to differentiate in HF space, says GlobalData
News | May 17, 2023

Farxiga’s expanded approval highlights potential to differentiate in HF space, says GlobalData

Farxiga is expected to have such a strong influence on the market due to the impressive results


Briefs: Dr. Reddy's Laboratories and Max Healthcare Institute
News | May 15, 2023

Briefs: Dr. Reddy's Laboratories and Max Healthcare Institute

Dr. Reddy's Laboratories has been issued a Form 483 with four observations


Nippon Express Italia receives IATA CEIV Pharma Certification for Its Facility near Milan Malpensa Airport
Supply Chain | May 13, 2023

Nippon Express Italia receives IATA CEIV Pharma Certification for Its Facility near Milan Malpensa Airport

Milan is also an important hub for the distribution of pharmaceuticals to the rest of Europe


Gilead acquires XinThera to strengthen pipeline in oncology
News | May 12, 2023

Gilead acquires XinThera to strengthen pipeline in oncology

Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors


USFDA approves GSK’s respiratory syncytial virus vaccine ‘Arexvy’
Drug Approval | May 12, 2023

USFDA approves GSK’s respiratory syncytial virus vaccine ‘Arexvy’

Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time


Baxter  to sell its BioPharma Solutions Business to Advent International and Warburg Pincus for US $4.25billion
News | May 09, 2023

Baxter to sell its BioPharma Solutions Business to Advent International and Warburg Pincus for US $4.25billion

Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation


IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to export in European market
Drug Approval | May 09, 2023

IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to export in European market

The certification issued by the EDQM verifies the compliance of pharmaceutical substances